Patient adherence to osteoporosis medications: problems, consequences and management strategies.
about
Clodronate: new directions of useCommunicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) programIcariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.Predictors of adherence to home rehabilitation exercises following anterior cruciate ligament reconstruction.Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.Screening, assessment, and treatment of osteoporosis for the nurse practitioner: key questions and answers for clinical practice--a Canadian perspectiveMethodological reflections on using pilot data from fracture patients to develop a qualitative study.Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update.Adherence to BCR-ABL inhibitors: issues for CML therapy.Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendationsBisphosphonate prescribing, persistence and cumulative exposure in Ontario, CanadaLevel of Adherence to Prophylactic Osteoporosis Medication amongst Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: A Cross-Sectional Study.Medication burden of Saudi Arabian women receiving antiresorptive therapyUpper gastrointestinal safety and tolerability of oral alendronate: A meta-analysisSecondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and olderPatient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinionsManagement of osteoporosis in the aging male: focus on zoledronic acid.Gender- and age-related treatment compliance in patients with osteoporosis in Germany.First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates.Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.Systematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancer.Vitamin K and musculoskeletal health in postmenopausal women.Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice.Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.Patient perceptions of the path to osteoporosis care following a fragility fracture.Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment.Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland.Clinical setting influences patterns of interaction between osteoporosis patient and physician.General medical practitioners' knowledge and beliefs about osteoporosis and its investigation and management.Evaluation of primary nonadherence to oral bisphosphonate therapy.MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study.Preferences of patients with post-menopausal osteoporosis treated with bisphosphonates--the VIVA II study.Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates.Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia.
P2860
Q26775773-8022AA87-DA22-47CF-B969-513DE0C3FC4CQ33345018-E5D8FA8D-785F-4AAA-BA63-8736D46ED2F7Q33644466-552AC782-42A2-49F1-B023-713AE6C7A67EQ33690781-DDE49609-0113-42E5-A58F-F3C4BA56C76FQ33712164-06F0157D-E6CD-4A29-9538-CA8067A19095Q33805602-87C56209-4101-4576-8684-0957BF574B7CQ34074981-693A1512-1C5F-49C1-A52D-21BB226531A6Q34082300-F189C4FB-A738-420D-8BCE-8220D276F927Q34272056-AFA7B989-7CC5-45A0-B1CE-92E401E9B325Q35595851-7869BD4A-5A13-41AD-81E9-2ECAEAF96EFDQ35693057-4E1F9B77-0B5A-4D9F-943F-B81A67D0A427Q35751437-C726EA58-B44A-4FEE-9E72-43B7A81212F3Q36154597-A332EC52-FB9E-4ABA-82C9-E821C8AC931CQ36311638-39B72044-28F9-445F-95EB-4A372C586BFEQ36502735-7660E6AA-54A4-4B77-908F-FA4CC60FDC71Q36820227-487E5323-7D4C-409B-8463-9E81D647A454Q36864709-718390C0-EEC1-48B9-9162-AAB57C039758Q36979427-8B637463-9B7F-4AC6-A596-F19872E6BFEAQ37008062-FF7BEA4C-03A8-4F35-ADBA-43AFA43A35D6Q37058784-0B6CB8BB-908F-4F94-9944-347283DBD6DEQ37337113-767E2EF3-8139-4FB7-95A8-8D70D27B3CF7Q37446418-07568AD8-C86A-47D7-820A-60E5DD2B6304Q37638700-1DFC4E11-84E7-46A7-9315-21B0FADBDBE9Q37768696-A9EE5526-8E80-4234-B52C-983A7EF9A7D7Q37998122-5A8DF925-7EB0-4F70-AC3D-48F41DC8F318Q38044039-4F73F9A6-69EA-4CF6-B73E-6ADF4A1FB272Q38222552-F950BE3C-1341-4A56-BC0C-2F79C2BEAC2DQ38341180-D1A846BE-A995-445A-9121-5B9CE2F7ED61Q39394834-FB6CABA0-C7D9-4A5A-842D-22109BC8313DQ40059033-88D3A805-532E-47E3-B5C7-BF4831FA26D1Q44042465-191EA948-9908-4CE3-A0E9-71B8035007C4Q44535216-58F9CA4D-1DC9-4947-B11B-4EF6A6F2FCCFQ44740806-63A833C1-8282-45B0-A3E8-560AC4D23EE0Q46070922-087666D3-5E27-4AF0-98BD-920C27E87AD8Q46706211-BD3A8535-38DC-4026-9E58-DA4164619508Q46788444-4442235B-6146-459F-AB9D-82C2C2E21E83Q47760896-E659D9C9-B34D-4EF4-8E09-DA588989A1B3Q48256965-ADBE205C-A17B-41FD-9B21-8888AC6089D5Q48474851-13335AEB-60FE-4462-875F-EA4ABA7A0A35Q48581497-A5569A4D-3ADC-4F33-B5EF-83395E830B45
P2860
Patient adherence to osteoporosis medications: problems, consequences and management strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Patient adherence to osteoporo ...... ces and management strategies.
@ast
Patient adherence to osteoporo ...... ces and management strategies.
@en
type
label
Patient adherence to osteoporo ...... ces and management strategies.
@ast
Patient adherence to osteoporo ...... ces and management strategies.
@en
prefLabel
Patient adherence to osteoporo ...... ces and management strategies.
@ast
Patient adherence to osteoporo ...... ces and management strategies.
@en
P2093
P2860
P1433
P1476
Patient adherence to osteoporo ...... nces and management strategies
@en
P2093
Alexandra Papaioannou
Courtney C Kennedy
Elaine Lau
Jonathan D Adachi
P2860
P356
10.2165/00002512-200724010-00003
P577
2007-01-01T00:00:00Z
P6179
1031757183